Filter by content type
Filter by year
Pepinemab – Anti-SEMA4D Antibody Treatment for Huntington’s Disease
CTAD 2021 presentation: SEMA4D blocking antibody, pepinemab , is a novel potential treatment for neurodegenerative disease: clinical proof of concept in HD supports clinical development in AD
Pagination
- Page 1
- Next page